BIONEUTRAL

BIO Gross Margin Analysis

53.1%

Higher than 26% of Healthcare sector peers

Updated 1499h ago·SEC filings & market data

Key Takeaway

Gross margin is the percentage of revenue a company keeps after paying direct production costs, so 53.1% means Bio-Rad retains $0.531 for every dollar of sales before other expenses.

Sector Performance

26th percentile

BIO

53.1%

Sector Median

68.3%

Sector Avg

-63.9%

Prior Period

52.3%(Jul 2026)

↑ Improving
📊

Deep Analysis

Gross margin is the percentage of revenue a company keeps after paying direct production costs, so 53.1% means Bio-Rad retains $0.531 for every dollar of sales before other expenses.

That level sits well below the sector median of 68.9%, placing Bio-Rad in the 24th percentile among healthcare peers, indicating most competitors convert a larger share of revenue into gross profit. The trend data is incomplete: year-over-year change is N/A, but quarter-over-quarter gross margin improved by 1.5 percentage points, from 52.3% to 53.1%. Because the current level is low relative to peers, the modest quarterly gain is not enough to close the gap, leaving margin pressure as an ongoing risk. At the same time, the sequential improvement offers a slight positive signal that cost or pricing conditions may be stabilizing. This mixed picture supports the overall NEUTRAL verdict, as the metric neither confirms a strong competitive advantage nor signals deterioration.

Frequently Asked Questions

What does the Gross Margin tell investors about BIO?

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

How is the Gross Margin calculated?

Gross Margin is calculated as: Gross Profit / Revenue.

How does BIO's Gross Margin compare to its sector?

BIO's Gross Margin of 53.1% compares to a Healthcare sector median of 68.3%, placing it in the 26th percentile.

Who are BIO's closest peers by Gross Margin?

The closest Healthcare peers by Gross Margin include: AMGN (68.2%), BLUE (68.4%), TECH (66.9%), EXAS (70.1%), ALGN (70.8%).

The Formula

Gross Profit / Revenue

Why It Matters

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

Advertisement

Master BIO's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full BIO research report →

Free account — no credit card

BIO

53.1%

Sector Median

68.3%

Sector Avg

-63.9%

How BIO's Gross Margin compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.